Advertisement
The Body: The Complete HIV/AIDS Resource
Follow Us Follow Us on Facebook Follow Us on Twitter Download Our App
Professionals >> Visit The Body PROThe Body en Espanol
Read Now: TheBodyPRO.com Covers AIDS 2014
  
  • Email Email
  • Comments Comments
  • Printable Single-Page Print-Friendly
  • Glossary Glossary

Press Release

Project Inform Urges Government Action Following the Positive Results of Two PrEP Studies in Heterosexual Men and Women

July 13, 2011

San Francisco, CA -- Two new studies of pre-exposure prophylaxis (PrEP) in heterosexuals in Africa have demonstrated that the antiretroviral (ARV) drug tenofovir, taken by HIV-negative people, substantially reduces the number of new HIV infections.

"The success of these new studies -- when combined with similar results from a recent international PrEP study in men who have sex with men (MSM) and transgender females -- validate that ARVs have the power to substantially alter the course of the AIDS epidemic worldwide," said Dana Van Gorder, Project Inform's Executive Director. "As a result, Project Inform urges the U.S. government to work quickly with other partners in the philanthropic and research communities to determine how best to roll out both PrEP and treatment-as-prevention programs on a global scale."

View Full Article


  
  • Email Email
  • Comments Comments
  • Printable Single-Page Print-Friendly
  • Glossary Glossary

Visit Project Inform's website to find out more about their activities, publications and services.
 
See Also
More News and Research on HIV Medications for HIV Prevention

No comments have been made.
 

Add Your Comment:
(Please note: Your name and comment will be public, and may even show up in
Internet search results. Be careful when providing personal information! Before
adding your comment, please read TheBody.com's Comment Policy.)

Your Name:


Your Location:

(ex: San Francisco, CA)

Your Comment:

Characters remaining:

Tools
 

Advertisement